Roche filed its definitive proxy statement and sent a letter to shareholders of Illumina Inc., urging them to tender their shares into Roche’s offer and vote for Roche’s independent director nominees and other proposals at the 2012 Illumina annual meeting to be held on 18 April 2012. A copy of the letter sent to Illumina shareholders from Severin Schwan, CEO of Roche Group, is posted on Roche's website.
The letter stated, "We are disappointed that Illumina’s Board of Directors rejected our offer on February 7, 2012 and has refused to engage in discussions with us. After Roche’s multiple attempts to engage were rebuffed, we decided to take our offer directly to you, Illumina’s shareholders, the true owners of the company.
"The best way for you, as a shareholder, to obtain value certainty today for your shares is to tender your shares into our offer and vote for Roche's independent director nominees and other proposals at the 2012 Illumina annual meeting to be held on April 18, 2012.
"At the 2012 annual meeting, you will have the ability to decide on the future of your investment. By electing our independent director nominees, and voting for the other proposals Roche has put forth, shareholders will have the best opportunity to have their voices heard and send a clear message to the management and Board of Illumina. We believe the election of our independent directors and passage of our proposals is the best path forward for shareholders to obtain maximum and certain value for their shares of Illumina."